| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.01B | — | -3.0% |
| Gross Profit | $1.10B | — | -1.5% |
| R&D Expense | $189.0M | — | -2.1% |
| SG&A Expense | $827.0M | — | +7.5% |
| Operating Income | $81.0M | — | -46.7% |
| Pre-tax Income | $16.0M | — | -57.9% |
| Income Tax | $3.0M | — | +103.0% |
| Net Income | $13.0M | — | -90.5% |
| EPS (Basic) | $0.07 | — | -91.1% |
| EPS (Diluted) | $0.07 | — | -91.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $561.0M | -36.1% | +5.1% |
| Accounts Receivable | $1.06B | +2.4% | +14.4% |
| Inventory | $1.09B | +2.2% | +25.8% |
| Current Assets | $3.58B | -7.2% | +17.4% |
| Total Assets | $14.10B | -1.4% | -3.0% |
| Current Liabilities | $3.35B | +6.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$189.0M | — | -751.7% |
| Capital Expenditures | $84.0M | — | -22.9% |
| Investing Cash Flow | -$77.0M | — | +32.5% |
| Financing Cash Flow | -$50.0M | — | +64.0% |
| Free Cash Flow | -$273.0M | — | -241.3% |
| +30.4% |
| Long-term Debt | $4.58B | -9.1% | -42.2% |
| Total Liabilities | $9.13B | -1.3% | -19.0% |
| Stockholders' Equity | $4.97B | -1.6% | +52.3% |